We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
(MM) | NASDAQ:MDAS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.35 | 0 | 01:00:00 |
Some of the comments about MedAssets captured by KLAS from interviews with executives, managers, analysts and physicians, include: (Note: The following is selected commentary that may not represent the whole of provider sentiment related to this product or service. Visit KLASresearch.com for a complete view.)
“Providers are faced with enormous pressure to deliver a healthy revenue cycle in the face of a fragmented, complicated and rapidly changing industry. We are delighted to be recognized by our customers as a KLAS category leader, driving impact and excellence in both claims management and the growing revenue cycle outsourcing market to help our customers be successful,” said Amy Amick, president of Revenue Cycle Management (RCM) of the new MedAssets-Precyse enterprise.
On January 27, Pamplona Capital Management completed its acquisition of MedAssets. It intends to combine MedAssets’ Revenue Cycle Management (RCM) segment, which currently serves more than 2,700 hospital clients and touches more than $450 billion in gross patient revenue annually, with Precyse, a Pamplona-owned health information management (HIM) services, technology, and education company.
“Moving forward, as we combine our capabilities with Precyse, we look forward to creating a national leader in the end-to-end outsourced revenue cycle services, technology and education market,” Amick added.
Produced by the KLAS research firm, results reported in the “2015/2016 Best in KLAS” report are based on industry feedback from thousands of healthcare executives and clinicians, with data gathered on software, services, and medical equipment.
“As healthcare continues to evolve, it is imperative that we seek innovation and constantly address the needs of a shifting market. The Best in KLAS and Category Leader winners are the ones making the greatest strides within their market segments. I congratulate each of you for your award,” said Adam Gale, CEO and president of KLAS. “KLAS is honored to work with talented healthcare providers who willingly share their experiences with us and make the Best in KLAS report possible. We also commend all the vendors who strive to improve their products and services in order to provide the best possible healthcare. It is truly a joint effort.”
To learn more about the MedAssets-Precyse enterprise, visit www.MedAssets-Precyse.com.
About MedAssets
MedAssets is a healthcare performance improvement company that combines strategic market insight with rapid operational execution to help providers sustainably serve the needs of their communities. More than 4,500 hospitals and 123,000 non- acute healthcare providers rely on our solutions to reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the System of CARE. www.medassets.com
About KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst from improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of health care information technology experience. Follow KLAS on twitter at www.twitter.com/KLASresearch.
Media Contact: Lea Volpe 678.248.8203 lvolpe@medassets.com
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions